Ignite Creation Date:
2025-12-26 @ 10:33 AM
Ignite Modification Date:
2025-12-31 @ 2:28 PM
Study NCT ID:
NCT05848128
Status:
COMPLETED
Last Update Posted:
2024-06-10
First Post:
2023-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
Sponsor:
Mimetogen Pharmaceuticals USA, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-11
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-27
First Submit QC Date:
None
Study First Post Date:
2023-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-06
Last Update Post Date:
2024-06-10
Last Update Post Date Type:
ACTUAL